ロード中...
Long-Term Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children with Autism Spectrum Disorder
Objective: A recent double-blind randomized placebo-controlled study demonstrated 3-month efficacy and safety of a novel pediatric-appropriate prolonged-release melatonin (PedPRM) for insomnia in children and adolescents with autism spectrum disorder (ASD) and neurogenetic disorders (NGD) with/witho...
保存先:
| 出版年: | J Child Adolesc Psychopharmacol |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Mary Ann Liebert, Inc., publishers
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6306655/ https://ncbi.nlm.nih.gov/pubmed/30132686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2018.0020 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|